Ho­ba, a Dan­ish biotech from No­vo, rais­es $25M to crack in­to dif­fi­cult pain and hear­ing loss fields

No­vo Hold­ings-found­ed biotech Ho­ba Ther­a­peu­tics has raised $25 mil­lion in the first close of a Se­ries A fi­nanc­ing to bankroll its in­ves­ti­ga­tion­al med­i­cines for pain …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER